
@ShahidNShah
While artificial intelligence (AI) can automate many functions within the middle revenue cycle, there remains a need for human expertise to manage complex, nuanced decisions to ensure high accuracy and proper context. Ultimately, AI should complement – not replace – humans to drive greater efficiency without compromising quality.
In revenue cycle management (RCM), the middle cycle refers to the phase between the front end, which is patient access and care delivery, and the back end, which encompasses billing and reimbursement. During the middle revenue cycle, the focus is generally on capturing patient data, documenting clinical procedures and treatments, and ensuring compliance with regulatory standards.
Continue reading at hitconsultant.net
In the pharmaceutical industry, compliance is more than just a checkbox; it is the foundation of trust, safety, and business sustainability. From medical clearance to post-market surveillance, …
Posted Mar 20, 2025 Pharmacology
Connecting innovation decision makers to authoritative information, institutions, people and insights.
Medigy accurately delivers healthcare and technology information, news and insight from around the world.
Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.
© 2025 Netspective Foundation, Inc. All Rights Reserved.
Built on Mar 28, 2025 at 1:45pm